The project led by Prof. Javier Montenegro, principal investigator at CiQUS (USC), receives support from the European Innovation Council to advance in the preclinical validation of a novel delivery sy...
Read moreResearchers from the Institute for Advanced Chemistry of Catalonia (IQAC) of Spanish National Research Council (CSIC) have developed a series of drugs, photosensitive molecules, which can be reversibl...
Read moreEn la fase III de un ensayo clínico se verifican aspectos de seguridad y eficacia del fármaco en estudio. Si los resultados obtenidos en esta fase son suficientes y positivos, las agencias regulador...
Read moreThe study evaluated the safety, tolerability, immunogenicity and efficacy of AELIX’s HTI T-cell therapeutic HIV vaccine in combination with Gilead’s investigational Toll-Like Receptor 7 (TLR7) ago...
Read moreLa fotofarmacología se ha convertido en una de las áreas de la medicina actual con mayor potencial de crecimiento. Esta rama científica de reciente creación, que apenas cuenta con una decena de ...
Read moreInvestigadores del Instituto de Investigación Sanitaria INCLIVA han realizado un trabajo de revisión de todos los tratamientos en desarrollo en la enfermedad rara distrofia miotónica tipo 1 (DM1) e...
Read moreConsidering the observed tolerability of this combination and initial efficacy in patients with MET-driven tumors, this combined approach is now being tested in the randomised phase III SAMETA study.
Read more3P Biopharmaceuticals (3P), a leading contract development and manufacturing organization (CDMO) specializing in process development and cGMP manufacturing for biological products complements its exis...
Read moreOrganic tissues will be recreated in miniature from pigs, chickens and ruminants and used during the different experimental phases to identify treatments and vaccines
Read more3P Biopharmaceuticals (3P), organización líder especializada en el desarrollo de procesos cGMP y fabricación de medicamentos biológicos (CDMO) estrena su tercera instalación en el polígono Mocho...
Read moreOff-label medicines, which are those prescribed under conditions other than those authorized in their SmPC, and therefore not covered by the regulatory agency for commercialization for that purpose, b...
Read moreAM-Pharma B.V. today announced that Professor Peter Pickkers, M.D., Ph.D., principal investigator of the Phase 3 REVIVAL study, will present data from the study at two upcoming scientific conferences....
Read more